解读困境:用保存的喷射分数 (HFpEF) 治疗心力衰竭的抗凝药
Fnu Jyotsna1, Kamran Mahfooz2, Haris Sohail3
1Medicine, Dr. Bhim Rao Ambedkar Medical College and Hospital, Sahibzada Ajit Singh Nagar, IND.
Cureus
|September 11, 2023
概括
保存喷射分数 (HFpEF) 的心力衰竭存在高血栓栓塞的风险. 这是一种抗凝血药物.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 保持喷射分数 (HFpEF) 的心力衰竭的特征是心室松受损和保持喷射分数.
- HFpEF日益普遍,与显著的发病率和死亡率相关,但治疗选择仍然有限.
- 这些患者表现出血栓栓塞事件的风险较高,促使对抗凝固疗法进行调查.
研究的目的:
- 分析抗凝和HFpEF之间的复杂关系.
- 审查目前关于抗凝剂在HFpEF中的疗效和安全性的证据.
- 探索潜在的策略来识别可能受益于抗凝药的HFpEF患者.
主要方法:
- 这篇叙述性综述综合了现有的临床试验数据和病理生理学的见解.
- 它检查了HFpEF中的原血栓状态,包括心脏纤维化和内皮功能障碍.
- 该审查还考虑了生物标志物和风险分层成像方面的进展.
主要成果:
- 对HFpEF抗凝的临床试验结果存在矛盾,提供有限的指导.
- 关于出血风险的担忧,特别是患有并发病的老年患者,使治疗决策复杂化.
- HFpEF涉及前血栓环境,但抗凝固的净益仍然不确定.
结论:
- 在HFpEF中抗凝固是一种治疗挑战,因为有效性不确定和出血风险.
- 精准医学方法,包括风险分层和个性化治疗,至关重要.
- 进一步的精心设计的临床研究对于澄清抗凝剂的作用和改善患者的治疗结果至关重要.
相关概念视频
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Heart Failure V: Medical Management
12
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
12
Anticoagulant Drugs: Low-Molecular-Weight Heparins
747
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
747
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
460
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
460
Heart Failure IV: Classification and Diagnostic Evaluation
19
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
Heart Failure Drugs: Diuretics
418
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
418


